Across autoimmune (MS, RA), neurodegenerative (AD), and inflammatory (SCI, OLP, periodontitis) models, PBMT consistently converges on redox-sensitive signaling hubs such as NF-κB, MAPK, and HIF-1α. The gene discussed is HIF1A; the disease is myeloid sarcoma.